NT

Nate Tower

Analyst - Therapeutics

United States

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $100,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Nate

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

BA
Balyasny Asset Management L.P.

2023

  • Analyst

    2023

SB
Samsara BioCapital

2020 - 2023

  • Senior Analyst

    2021 - 2023

  • Analyst

    2020 - 2021

SF
Stifel Financial Corp.

2018 - 2020

  • Associate - Equity Research

    2018 - 2020

    Biotechnology - CNS, Rare Disease

SI
Stephens Inc.

2015 - 2018

  • Associate - Equity Research

    2015 - 2018